Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study

SUMMARY: A 48-week, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial (the TWICE study) conducted in Japanese primary osteoporosis patients with a high risk of fractures demonstrated that a 28.2-μg twice-weekly regimen of teriparatide can provide comparabl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Osteoporos Int
Päätekijät: Sugimoto, T., Shiraki, M., Fukunaga, M., Kishimoto, H., Hagino, H., Sone, T., Nakano, T., Ito, M., Yoshikawa, H., Minamida, T., Tsuruya, Y., Nakamura, T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer London 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811384/
https://ncbi.nlm.nih.gov/pubmed/31392401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-019-05111-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia